Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Oxybate in Binge Eating Disorder
NCT00514995Phase 3Completed
- Sponsor
- Lindner Center of HOPE
- Start
- Aug 2007
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of sodium oxybate in binge eating disorder (BED), sponsored by Lindner Center of HOPE. Primary endpoint: Weekly frequency of binge-eating episodes at 16 weeks. Started Aug 2007; status: completed.
02
Drugs
sodium oxybate
03
Conditions
binge eating disorder (BED)
Beyond the preview
Go deeper on NCT00514995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00514995.